HRTX
Heron Therapeutics Inc
Price:  
2.20 
USD
Volume:  
1,054,068.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX Relative Valuation

-152.7%
Upside

As of 2025-07-09, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (1.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.20 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -152.7%.

The range of the Relative Valuation is (0.93) - (1.24) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.1x - 26.4x 25.7x
Forward P/E multiples 16.1x - 24.3x 19.7x
Fair Price (0.93) - (1.24) (1.16)
Upside -142.1% - -156.3% -152.7%
2.20 USD
Stock Price
(1.16) USD
Fair Price

HRTX Relative Valuation - Historical P/E Data

Date P/E
2025-07-08 -43.21
2025-07-07 -42.13
2025-07-03 -43.11
2025-07-02 -42.13
2025-07-01 -42.52
2025-06-30 -40.57
2025-06-27 -41.94
2025-06-26 -42.33
2025-06-25 -42.13
2025-06-24 -42.13
2025-06-23 -41.35
2025-06-20 -39.19
2025-06-18 -39.19
2025-06-17 -38.21
2025-06-16 -39.78
2025-06-13 -37.82
2025-06-12 -39.39
2025-06-11 -40.37
2025-06-10 -41.54
2025-06-09 -41.54
2025-06-06 -41.15
2025-06-05 -39.19
2025-06-04 -39.98
2025-06-03 -39.19
2025-06-02 -37.82
2025-05-30 -36.84
2025-05-29 -37.43
2025-05-28 -35.86
2025-05-27 -37.04
2025-05-23 -36.25
2025-05-22 -36.65
2025-05-21 -36.84
2025-05-20 -37.63
2025-05-19 -37.63
2025-05-16 -38.61
2025-05-15 -36.65
2025-05-14 -33.71
2025-05-13 -36.06
2025-05-12 -40.17
2025-05-09 -41.35
2025-05-08 -42.52
2025-05-07 -44.29
2025-05-06 -47.42
2025-05-05 -41.74
2025-05-02 -45.27
2025-05-01 -46.05
2025-04-30 -47.42
2025-04-29 -45.86
2025-04-28 -45.66
2025-04-25 -45.07